The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Here are the key moments that will take place on the day Article 50 is triggered and the UK begins the formal process of leaving the EU.
A man has been charged in connection with a crash which killed a four-year-old girl.
Philip, 95, used the vehicle for engagements in London allowing him to travel around the city unnoticed.